LuyePharma

• HOME
• ABOUT LUYEPHARMA
  • Company Overview
  • Corporate Value
  • Board and Management
  • Social Responsibility
• GROUP COMPANIES
• PRODUCTS
  • Oncology Products
    • CMNa®
      (Sodium Glycididazole Injection)
    • LIPUSU®
      (Paclitaxel Liposome Injection)
    • TIANDIXIN®
      (Lentinan Injection)
    • TIANDIDA®
      (Amifostine Injection)
  • Orthepaedics Products
    • MAITONGNA® (Sodium Aescinate Injection)
    • SIDINUO®
      (Elcatonin injection)
    • OKAI®
      (Sodium Aescinate tablet)
    • OLAI®
      (Compound Sodium Aescinate Gel)
    • OTONG®
      (Capsaicin Gel)
  • Cardiovascular Products
    • XUEZHIKANG®
      (Red Yeast Rice Capsules)
  • Hepatology Products
    • LUTINGNUO®
      (Reduced Glutathione Injection)
  • Neurlolgy Products
    • JINSIPING®
      (Selegiline Hydrochloride Tablet)
  • Gynecology Products
    • XIMINGTING®
      (Largetrifoliolious Bugbane Rhizome Tablet)
  • Gastroenterlology Product
    • NUOSEN®
      (Sodium Pantoprazole Injection)
    • SAILIMAI®
      (Smectite Dispersible Tablet)
    • PANTOPRAZOLE PELLETS CAPSULE
    • Smectite Powder Sachet
• R&D AND PIPELINE
• ACTIVITIES AND EVENTS
• INVESTOR RELATIONS
  • Investor Relations Home
  • Financial Statements
  • Financial Highlights
  • Financials Ratios
  • Financial Calendar
  • Stock Information
  • Stock Fundamentals
  • Investment Calculator
  • Newsroom
  • Streaming Video
  • Presentation Slides
  • Email Alerts
• CAREER
• CONTACT US

Newsroom

By Year : Latest  |  All  |   2009  |  2008  |  2007  |  2006  |  2005  |  2004

• May 25, 2009
• Luye Pharma Opens Gateway For Sale Of Proprietary Drugs In Australia With TGA Certification; Eyes Sales In 34 PIC Member Countries

• May 13, 2009
• Luye Pharma Achieves 59.1% Growth In 1QFY09 Pre-Tax Profit To RMB 35.4 Million

• May 13, 2009
• First Quarter Financial Statement And Dividend Announcement

• Apr 24, 2009
• Results Of Annual General Meeting

• Apr 08, 2009
• Notice Of Annual General Meeting

• Apr 07, 2009
• Luye Pharma Awarded Internationally Recognised GLP Certification

• Mar 26, 2009
• Change Of Name And Trading Counter Name On The SGX-ST

• Mar 06, 2009
• Results Of Special General Meeting

• Feb 27, 2009
• AsiaPharm Achieves 27.9% Revenue Growth To RMB 651.0 Million Despite Challenging Operating Conditions

• Feb 27, 2009
• Full Year Financial Statement And Dividend Announcement

• Feb 11, 2009
• Notice Of Special General Meeting

• Jan 19, 2009
• Report Of Persons Occupying Managerial Positions Who Are Related To A Director; CEO Or Substantial Shareholder

• Dec 05, 2008
• Change Of Assistant Secretary & Resignation Of Secretary

• Nov 12, 2008
• AsiaPharm's 9MFY2008 Turnover Increased RMB 99.2 Million Or 27.2% To RMB 464.2 Million Despite Challenging Operating Conditions In The PRC

• Nov 12, 2008
• Third Quarter Financial Statement And Dividend Announcement

• Oct 23, 2008
• Proposed Acquisition Of Land, Construction Of New Production Plant And Purchase Of New Equipment ("Acquisition")

• Oct 14, 2008
• Divestment Of Guangzhou Lifetech Jiuzhoutong New/Special Drug Company

• Aug 14, 2008
• Announcement Of Appointment Of Non-Executive Director

• Aug 14, 2008
• Announcement Of Appointment Of Non-Executive Director

• Aug 13, 2008
• Second Quarter Financial Statement And Dividend Announcement